TRIFLURIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Trifluridine patents expire, and what generic alternatives are available?
Trifluridine is a drug marketed by Hikma and Sandoz and is included in two NDAs.
The generic ingredient in TRIFLURIDINE is trifluridine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trifluridine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluridine
A generic version of TRIFLURIDINE was approved as trifluridine by SANDOZ on October 6th, 1995.
Summary for TRIFLURIDINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 62 |
Patent Applications: | 4,183 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIFLURIDINE |
DailyMed Link: | TRIFLURIDINE at DailyMed |
Recent Clinical Trials for TRIFLURIDINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yonsei University | Phase 1/Phase 2 |
Merck Sharp & Dohme LLC | Phase 3 |
Taiho | Phase 2 |
Pharmacology for TRIFLURIDINE
Drug Class | Nucleoside Analog Antiviral Nucleoside Metabolic Inhibitor |
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for TRIFLURIDINE
Anatomical Therapeutic Chemical (ATC) Classes for TRIFLURIDINE
US Patents and Regulatory Information for TRIFLURIDINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | TRIFLURIDINE | trifluridine | SOLUTION/DROPS;OPHTHALMIC | 205438-001 | Jul 28, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | TRIFLURIDINE | trifluridine | SOLUTION/DROPS;OPHTHALMIC | 074311-001 | Oct 6, 1995 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |